Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells.
Zeng C, Nie D, Wang X, Zhong S, Zeng X, Liu X, Qiu K, Peng X, Zhang W, Chen S, Zha X, Chen C, Chen Z, Wang W, Li Y.
Zeng C, et al. Among authors: qiu k.
Mol Cancer. 2024 Oct 28;23(1):240. doi: 10.1186/s12943-024-02162-0.
Mol Cancer. 2024.
PMID: 39465372
Free PMC article.